Literature DB >> 33509123

Continuous hypergammaglobulinemia and proteinuria after the recovery of the visceral Leishmaniasis: a case report.

Linfeng Zou1,2, Gang Chen3, Yangzhong Zhou2, Wei Ye2, Yubin Wen2, Limeng Chen2, Xuemei Li2.   

Abstract

BACKGROUND: Kidney involvement of visceral Leishmaniasis is previously reported, but knowledge is limited. Hypergammaglobulinemia is common in visceral leishmaniasis patients. Whether hypergammaglobulinemia after leishmaniasis depletion can cause kidney injury is not well reported yet. CASE
PRESENTATION: We reported a patient who recovered from visceral Leishmaniasis but showed persistent hypergammaglobulinemia and elevated urinary protein. Kidney biopsy showed glomerular hypertrophy with mild segmental mesangial proliferation without tubulointerstitial involvement in light microscopy. No immune complex deposit was found in the mesangial area by neither immunofluorescent staining nor electronic microscope. Increased lysosomes were observed in proximal tubules by electronic microscope. Valsartan was administered to decrease urinary protein, and no immune-suppressive therapy was added. The urinary protein and serum IgG level gradually dropped, and serum creatinine level remained stable during three- month follow up.
CONCLUSIONS: Hypergammaglobulinemia is unlikely to cause renal structural or functional damage in the short term. Angiotensin blockade significantly reduced urine protein, with a minor effect on IgG elimination.

Entities:  

Keywords:  Case report; Hypergammaglobulinemia; Visceral Leishmaniasis

Mesh:

Substances:

Year:  2021        PMID: 33509123      PMCID: PMC7844912          DOI: 10.1186/s12879-021-05819-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  18 in total

1.  Immune complex glomerulonephritis in experimental kala-azar. II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters.

Authors:  A Sartori; M C Roque-Barreira; J Coe; A Campos-Neto
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation.

Authors:  C Zoja; R Donadelli; S Colleoni; M Figliuzzi; S Bonazzola; M Morigi; G Remuzzi
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

3.  Renal function improvement with pentavalent antimonial agents in patients with visceral leishmaniasis.

Authors:  Elizabeth F Daher; Natália A Rocha; Michelle J C Oliveira; Luiz F L G Franco; Jobson L Oliveira; Geraldo B Silva Junior; Krasnalhia Lívia S Abreu; Guilherme A L Henn; Alice M C Martins; Alexandre B Libório
Journal:  Am J Nephrol       Date:  2011-03-11       Impact factor: 3.754

4.  Visceral leishmaniasis-associated nephropathy in hospitalised Brazilian patients: new insights based on kidney injury biomarkers.

Authors:  Gdayllon C Meneses; Elizabeth De Francesco Daher; Geraldo B da Silva Junior; Gabriela F Bezerra; Thaiany P da Rocha; Isabella E P de Azevedo; Alexandre B Libório; Alice M C Martins
Journal:  Trop Med Int Health       Date:  2018-07-31       Impact factor: 2.622

5.  The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.

Authors:  T A Waldmann; W Strober; R P Mogielnicki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

Review 6.  Reduction of proteinuria with angiotensin receptor blockers.

Authors:  Jan Galle
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-07

7.  Interstitial nephritis in human kala-azar.

Authors:  M I Duarte; M R Silva; H Goto; E L Nicodemo; V Amato Neto
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

8.  Innate Immune B Cell Activation by Leishmania donovani Exacerbates Disease and Mediates Hypergammaglobulinemia.

Authors:  Sasha Silva-Barrios; Mélina Smans; Claudia U Duerr; Salman T Qureshi; Jörg H Fritz; Albert Descoteaux; Simona Stäger
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

9.  Renal involvement in visceral leishmaniasis.

Authors:  M Dutra; R Martinelli; E M de Carvalho; L E Rodrigues; E Brito; H Rocha
Journal:  Am J Kidney Dis       Date:  1985-07       Impact factor: 8.860

10.  Membranoproliferative glomerulonephritis due to visceral leishmaniasis in an HIV patient.

Authors:  Ricardo Enríquez; Ana Esther Sirvent; Sergio Padilla; Paula Toro; María Sánchez; Isabel Millán
Journal:  Am J Case Rep       Date:  2015-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.